Purdue Tries To Knock Out Generic OxyContin ANDA
Connecticut-based Purdue, along with its subsidiary P.F. Laboratories Inc. and partner Rhodes Technologies, brought the suit after Varam and KVK sought federal approval of an abbreviated new drug application to make and sell a generic version of OxyContin before Purdue’s four patents had expired.
“Varam and KVK’s submission of ANDA No....
To view the full article, register now.